Hologic Medical (HOLX) Forward Price-to-Revenue Multiple

hologic.com (HOLX) - corporate logo

The forward P/S of Hologic, Inc. (HOLX) reflects the business valuation trend, where 2.10 represents the current metric. Hologic, Inc. (HOLX) is integrating AI algorithms into mammography to automate image analysis. The company leads the women's health sector by developing high-precision molecular tests. A sophisticated equipment ecosystem and strict FDA regulations ensure a steady client inflow and high barriers to entry against competition.

HOLX hologic.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 04/18/2026

Hologic Medical - analytical breakdowns and key metrics (HOLX)

- market price and analyst price targets:
Price Chart Hologic|HOLX - Analyst Median Target
- market capitalization details:
Market Valuation Hologic Medical|HOLX - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share Hologic|HOLX - Company Net Assets|Market Capitalization to Book Value Ratio hologic.com|HOLX - Company Assets
- debt and solvency information:
Total Debt to Capital Hologic, Inc.|HOLX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Hologic, Inc.|HOLX - Company Total Debt Obligations|Debts to Book Capitalization Hologic Medical|HOLX - Company Long-Term Liabilities|Company Short-Term Debts Hologic|Quick Liquidity hologic.com
- business earnings and investment ratios data:
HOLX - Company Net Income|Future Profit Hologic, Inc.|HOLX - Company Value to Net Income|Forward P/E Multiple Hologic Corp|HOLX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hologic Medical|HOLX - Operating profit before depreciation charges|Net earnings per share for the last 12 months Hologic|HOLX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth hologic.com|HOLX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Hologic, Inc.
- sales and revenue data:
HOLX - Company Annual Revenue|Company Projected Revenue Hologic|HOLX - Market Cap to Revenue|Forward P/S Multiple Hologic Medical
Comprehensive company analysis:Hologic HOLX
Product sample of Hologic Medical

When selecting high-quality blue-chip assets, investors utilize the forward P/S ratio to assess the market premium for future business scalability. This indicator compares current market capitalization with expected sales volume, allowing them to differentiate justified re-ratings from speculative spikes. For Hologic, Inc. (HOLX), given its non-cyclical demand for mammography, the forward price-to-sales ratio confirms stable cash flows and determines the fair value of the shares.

Competitors of Hologic, Inc. (HOLX)

Price-to-Projected Revenue Ratio Stryker SYK|Market Cap to Expected Sales Ratio Medtronic Inc. (MDT)|PHG: Forward Price-to-Revenue Multiple|Forward Price to Sales SNN (Smith+Nephew)|Carlisle Companies (CSL) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple integer.net|LIVN (LivaNova) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AdaptHealth Corp AHCO|Forward P/S Multiple SSII|Avanos Corp - Market Cap to Projected Revenue|Forward P/S Multiple SI (Shoulder Innovations)|Market Cap to Expected Sales Ratio viemed.com (VMD)|Inogen Medical - Forward P/S Multiple|Owlet, Inc. (OWLT) - Forward Price-to-Revenue Multiple|QIPT: Forward P/S Multiple|Precision Optics Corporation (POCI) - Forward P/S Multiple|Price-to-Projected Revenue Ratio PAVmed, Inc.|Price-to-Projected Revenue Ratio TIVC|Forward Price-to-Revenue Multiple MOVE (Movano)|NUVO (Holdco Nuvo Group) - Forward Price to Sales